Nexalin Technology (NXL) FCF Margin (2021 - 2026)
Nexalin Technology's (NXL) quarterly FCF Margin came in at 11787.72% in Q1 2026, down 831042.0% year-on-year from N/an in Q1 2025, and down 1664.99% quarter-over-quarter from 667.86% in Q4 2025.
Nexalin Technology (NXL) FCF Margin (2021 - 2026) Analysis & Trends
Nexalin Technology's FCF Margin history runs 6 years deep, the most recent figure standing at 11787.72% for Q1 2026.
- On a quarterly basis, FCF Margin fell 831042.0% year-over-year to 11787.72% in Q1 2026; TTM through Mar 2026 was 1920.92%, a 159437.0% increase from a year earlier, with the FY2025 full-year figure at 1643.53%, up 69429.0% from the prior year.
- FCF Margin eased to 11787.72% in Q1 2026 per NXL's latest filing, from 667.86% in the prior quarter.
- Across five years, FCF Margin topped out at 39.17% in Q2 2022 and bottomed at 11787.72% in Q1 2026.
- The 5-year median for FCF Margin is 2359.09% (2022), against an average of 3196.93%.
- Across the five-year window, FCF Margin jumped 350623 bps in 2025 and sank 831042 bps in 2026, its largest moves.
- Year by year, FCF Margin stood at 2359.09% in 2022, then slumped by 107 bps to 4889.12% in 2023, then climbed by 15 bps to 4174.09% in 2024, then soared by 84 bps to 667.86% in 2025, then tumbled by 1665 bps to 11787.72% in 2026.
- Per Business Quant, the three latest NXL FCF Margin figures stand at 11787.72% (Q1 2026), 667.86% (Q4 2025), and 8079.0% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | -11,787.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,787.72% |
| Dec 31, 2025 | -667.86% |
| Sep 30, 2025 | -8,079.00% |
| Jun 30, 2025 | -1,299.32% |
| Mar 31, 2025 | -3,477.30% |
| Dec 31, 2024 | -4,174.09% |
| Sep 30, 2024 | -2,220.89% |
| Jun 30, 2024 | -4,643.87% |
| Mar 31, 2024 | -970.23% |
| Dec 31, 2023 | -4,889.12% |
| Sep 30, 2023 | -2,907.54% |
| Jun 30, 2023 | -2,294.91% |
| Mar 31, 2023 | -4,301.86% |
| Dec 31, 2022 | -2,359.09% |
| Sep 30, 2022 | -173.05% |
| Jun 30, 2022 | -39.17% |
| Mar 31, 2022 | -62.87% |
| Dec 31, 2021 | -1,704.62% |